Загрузка...
FGF19 and FGF21: In NASH we trust
OBJECTIVE: FGF19 and FGF21 have shown therapeutic promise since their discovery, attested by the fact there are at least 5 assets that activate the FGFR/KLB pathway and one FGF19 analog in clinical development. METHODS: We performed a detailed analyses of published preclinical and clinical data to o...
Сохранить в:
| Опубликовано в: : | Mol Metab |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085573/ https://ncbi.nlm.nih.gov/pubmed/33383173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2020.101152 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|